Skip to content
Screener

Innoviva, Inc. INVA Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Merck & Co. logo
Merck & Co.MRK
$19.6B+11.0%
Savara logo
SavaraSVRA
$1.89M+83.8%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$25.18M-2.3%
Pfizer logo
PfizerPFE
AbbVie logo
AbbVieABBV
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP

Other financials

Income statement

See full
Revenue$119.6M+19.3%
Gross profit$90.6M+9.0%
Operating income$50.9M+4.3%
Net income-$83.4M-231%
EPS (diluted)-$1.14-248%

Balance sheet

See full
Cash & equivalents$570.4M+43.5%
Total debt$269.7M-40.2%
Total equity$1.2B
Total assets$1.7B+27.7%

Cash flow

See full
Operating cash flow$52.0M+17.9%
CapEx$429.0K
Free cash flow$51.5M+16.9%

Valuation

See full
Market cap$1.49B+20.6%
Enterprise value$1.19B-7.6%
P/E4.2×-27.8×
P/S3.4×+0.1×

Profitability

See full
Gross margin72.2%-10.9pp
Operating margin36.9%-10.7pp
Net margin81.2%+70.8pp
FCF margin43.1%-11.1pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio16×+13.4×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Innoviva, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:26 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335235
Line itemJune 30, 2026 / (Unaudited)December 31, 2025 / *
Right-of-use assets10,37710,929
Goodwill17,90517,905
Intangible assets168,976182,156
Other assets39,89440,744
Total assets$1,702,727$1,635,165
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$4,016$4,966

Item 1. Financial Statements

FAQ

What is Innoviva, Inc.'s deferred tax assets and other non-current assets?
Innoviva, Inc. (INVA) reported deferred tax assets and other non-current assets of $39.89M in Q2 2026.
How has Innoviva, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Innoviva, Inc.'s deferred tax assets and other non-current assets decreased by 3.1% year-over-year, from $41.18M to $39.89M.
What is the long-term trend for Innoviva, Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Innoviva, Inc.'s deferred tax assets and other non-current assets has grown at a 185.7% compound annual growth rate (CAGR), from $214K to $40.74M.
What does deferred tax assets and other non-current assets mean?
Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Ask your AI about Innoviva, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude